INFU Stock Forecast: InfuSystem Holdings, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for InfuSystem Holdings, Inc. is $18. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 100 of 100 as at 21 Nov 2026 — among the strongest tenth.
One number for the whole business
Consensus tells you what everyone already believes. The model scores InfuSystem Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (98): The business earns solid, repeatable profits on what it owns.
Volatility (62): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
INFU stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on INFU, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 5 Aug 2026 | B. Riley Securities | Reiterates | Buy | — |
| 25 Feb 2026 | Roth Capital | Reiterates | Buy | — |
| 5 Nov 2025 | Roth Capital | Reiterates | Buy | — |
| 22 July 2025 | Roth Capital | Initiates | Buy | — |
| 26 Sept 2024 | B. Riley Securities | Initiates | Buy | — |
| 26 Apr 2021 | Northland Capital Markets | Initiates | Outperform | — |
| 31 Aug 2020 | Craig-Hallum | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for INFU.
This page is one stock. Monday covers all of them.
INFU appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
INFU vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, InfuSystem Holdings, Inc. returned +55.6% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
INFU analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 31.8×
- Price / sales
- 1.9×
- Price / book
- 4.4×
- EV / EBITDA
- 11.9×
Cheaper than 27% of US stocks
Cheaper than 49% of US stocks
Cheaper than 21% of US stocks
Cheaper than 48% of US stocks
- Revenue growth (YoY)
- 3.0%
- Earnings growth (YoY)
- 39.7%
- Gross margin
- 58.0%
- Operating margin
- 8.4%
- Net margin
- 6.5%
Higher than 35% of US stocks
Higher than 72% of US stocks
Higher than 71% of US stocks
Higher than 61% of US stocks
Higher than 60% of US stocks
- Return on equity
- 15.8%
- Return on assets
- 7.5%
- Dividend yield
- —
Higher than 75% of US stocks
Higher than 86% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
InfuSystem Holdings, Inc. has a market value of $281.7M and an enterprise value of $296.4M.
Revenue in the twelve months to 30 June 2026: $143.3M. The latest quarter grew 2.6% year on year.
Net income over the same four quarters: $8.5M, a 6.0% net margin.
Diluted earnings per share, trailing twelve months: $0.41.
Free cash flow in the twelve months to 30 June 2026: $12.6M.
InfuSystem Holdings, Inc. spent $9.3M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 31.8×; forward P/E: 25.0× — the forward figure prices analyst consensus estimates, not reported earnings.
InfuSystem Holdings, Inc. employs 461 people — $311K of revenue per employee.
Data provided by Twelve Data
INFU and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at INFU’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own InfuSystem Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about INFU
What is the INFU stock price forecast for 2026-2027?
The median 12-month analyst price target for InfuSystem Holdings, Inc. is $18, with estimates ranging from $18 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is INFU stock a buy right now?
Of the 3 analysts covering InfuSystem Holdings, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks InfuSystem Holdings, Inc. 100 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank INFU?
As at 21 Nov 2026, InfuSystem Holdings, Inc. ranks 100 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (98 of 100).
Will INFU stock go up?
No one can know that. What the data says: the median 12-month target from 3 analysts is $18, and Ticker Nerd's factor model ranks InfuSystem Holdings, Inc. 100 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the INFU stock forecast for 2030?
No analyst covering InfuSystem Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for INFU are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $18 to $20 over the next 12 months.
How has INFU stock performed over the past year?
InfuSystem Holdings, Inc. returned +55.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does InfuSystem Holdings, Inc. do?
InfuSystem Holdings, Inc. is a healthcare services company focused on infusion pump management and related support for hospitals, oncology practices, surgery centers, and other alternate-site care providers. InfuSystem provides electronic ambulatory infusion pumps, disposable supply kits, and associated clinical, biomedical, logistics, billing, maintenance, and repair services that support outpatient therapy workflows.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a healthcare services company focused on infusion pump management and related support for hospitals, oncology practices, surgery centers, and other alternate-site care providers. InfuSystem provides electronic ambulatory infusion pumps, disposable supply kits, and associated clinical, biomedical, logistics, billing, maintenance, and repair services that support outpatient therapy workflows. Its offerings serve oncology clinics, home infusion providers, and other care settings where durable medical equipment and ongoing treatment coordination are required. The company operates through two core segments, Patient Services and Device Solutions, combining equipment access with technical servicing and patient support. Headquartered in Rochester Hills, Michigan, InfuSystem plays a specialized role in the medical device services market by helping healthcare providers manage infusion therapy across clinic-to-home care environments in the United States and Canada.
CEO Ms. Carrie A. Lachance B.S.N., M.B.A., R.N. · 461 employees · United States · https://www.infusystem.com